Psyence Biomedical PBM
NASDAQ PBM
$5.46 +0.03 (+0.55%)
At close: Sep 30, 2026 · 4:00 PM EDT

Psyence Biomedical (PBM) Revenue (2023)

Updated

Psyence Biomedical's Revenue was $1.13 million in the quarter ended Sep 30, 2023.

Analysis

Psyence Biomedical (PBM) Revenue (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Psyence Biomedical 3.00 Mn 3.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -62,776.00
API Access

Psyence Biomedical Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PBM&period=max&api_key=YOUR_API_KEY